QinYLiangXWuH, et al. Development and validation of a modified Khorana score for predicting venous thromboembolism in newly diagnosed stage IV lung cancer. Angiology. 2025;76:264-270.
2.
IchtOLeaderABatatE, et al.Arterial and venous thromboembolism in ALK-rearrangement-positive non-small cell lung cancer: a population-based cohort study. Oncol. 2023;28:e391-e396.
3.
RoopkumarJPoudelSKGervasoL, et al.Risk of thromboembolism in patients with ALK- and EGFR-mutant lung cancer: a cohort study. J Thromb Haemostasis. 2021;19:822-829.
4.
LyonARLópez-FernándezTCouchLS, et al.2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43:4229-4361.
5.
HaggstromLParmarGBrungsD. Central venous catheter thrombosis in cancer: a multi-centre retrospective study investigating risk factors and contemporary trends in management. Clin Med Insights Oncol. 2020;14:1179554920953097.
6.
TemrazSMoukalledNGerotziafasGT, et al.Association between radiotherapy and risk of cancer associated venous thromboembolism: a sub-analysis of the COMPASS-CAT study. Cancers. 2021;13:1033.
